Fresenius SE & Co. KGaA buy Quitte
Start price
05.11.13
/
50%
€32.00
Target price
25.11.13
€33.67
Performance (%)
5.58%
End price
25.11.13
€33.78
Summary
This prediction ended on 25.11.13 with a price of €33.78. The BUY prediction by Quitte finished with a performance of 5.58%. Quitte has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 1.780% | 1.780% | 14.378% | -23.096% |
| iShares Core DAX® | -1.215% | 4.788% | 16.604% | 15.523% |
| iShares Nasdaq 100 | -1.911% | 1.109% | 19.364% | 31.093% |
| iShares Nikkei 225® | -3.171% | 5.626% | 10.519% | 1.800% |
| iShares S&P 500 | -1.029% | 1.792% | 20.514% | 35.443% |
Comments by Quitte for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
gute Prognose für Medizinaktie
die Aktie ist träge, aber relativ sicher. Und gerade wurden gute Quartalszahlen bekannt gegeben . Für längerfristig eine gute Anlage